Tara Siringhaus

Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease.

C. Lines, M. Kryger, J. Wagner, 2015, Respiratory medicine.

Efavirenz does not meaningfully affect the single dose pharmacokinetics of 1200 mg raltegravir

J. Brejda, R. Krishna, P. Larson, 2016, Biopharmaceutics & drug disposition.